Cancer BiologybioRxivPreprint
Synergistic Antitumor Activity of SUMO1 degrader and Oxaliplatin through G6PD Inhibition in Colorectal Cancer
Sung Han Jung, Rakhim Roy, Yin Quan Zhao…·Anita C. Bellail
This study shows that combining SUMO1 degrader HB007 with oxaliplatin enhances antitumor effects in colorectal cancer by inhibiting G6PD and inducing ROS-mediated apoptosis.
DOI 10.1101/2025.04.08.647644